Hyderabad: Aurobindo Pharma Ltd (APL) has reported a growth of 22% in turnover at Rs512.9 crore and 61.7% rise in net profit at Rs58.6 crore during the quarter ended 30 June. The financials translate into an earnings per share (EPS) of Rs10.97 on an equity base of Rs26.6 crore.
In the same quarter last year, the company reported a turnover of Rs420.2 crore and a post-tax profit of Rs36.2 crore, translating into an EPS of Rs6.80. During the quarter under review, Aurobindo Pharma recorded exports of Rs277.2 crore—constituting 54.5% of its turnover—which are up 10.2% from Rs252 crore in the same quarter of the previous fiscal. Formulations sales netted Rs134.3 crore, or more than 26% of its sales, while Rs378.6 crore or close to 74% of sales came from active pharmaceutical ingredients.
Shares of Aurobindo Pharma closed at Rs652 on Tuesday, down 0.99% on the Bombay Stock Exchange.